维普中文期刊产品整合服务
28篇 您的检索式:作者名="BERTUS"
    题名 作者 年代 出处 被引量
1TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development显示文摘AIM: To investigate the association between tumor protein 53(TP53) codon 72 polymorphisms and the risk for inflammatory bowel disease(IBD) development.METHODS: Numerous genetic and epigenetic drivers have been identified for IBD including the TP53 gene. Pathogenic mutations in TP53 gene have only been reported in 50% of colorectal cancer(CRC) patients. A single nucleotide polymorphism(SNP) in the TP53 gene resulting in the presence of either arginine(Arg)or proline(Pro) or both at codon 72 was shown to alter TP53 tumor-suppressor properties. This SNP has been investigated as a risk factor for numerous cancers,including CRC. In this study we analyzed TP53 codon 72 polymorphism distribution in 461 IBD,181 primary sclerosing cholangitis patients and 62 healthy controls. Genotyping of TP53 was performed by sequencing and restriction fragment length polymorphism analysis of genomic DNA extracted from peripheral blood. RESULTS: The most frequent TP53 genotype in IBD patients was Arg/Arg occurring in 54%-64% of cases(and in only 32% of controls). Arg/Pro was the most prevalent genotype in controls(53%) and less common in patients(31%-40%). Pro/Pro frequency was not significantly different between controls and IBD patients. CONCLUSION: The data suggests that the TP53 codon 72 Arg/Arg genotype is associated with increased risk for IBD development.Natalia Volodko Mohamed Salla Bertus Eksteen Richard N Fedorak Hien Q Huynh Shairaz Baksh 2015World Journal of Gastroenterology2015,21,36:9
2Understanding of chemoprophylaxis and concordance in inflammatory bowel disease显示文摘AIM:To assess patients' understanding for the reasons for taking 5-aminosalicylic acid or ursodeoxycholic acid as chemoprophylaxis against colorectal carcinoma associated with in? ammatory bowel disease (IBD). METHODS: A questionnaire-based study using a 5 point opinion scale was performed. One hundred and ninety-two patients with colitis only and 74 patients with primary sclerosing cholangitis and IBD were invited to take part. RESULTS: Overall response rate was 58%. Sixtyfour percent of patients claimed full concordance with chemoprophylaxis for maintenance of remission. Eightyfour percent of patients considered daily concordance during remission to be very important. Seventy-five percent stated they understood the reasons for taking the drugs. However, only 50% of the patients were aware of any link of their condition to bowel cancer. Seventy-nine percent of patients felt their concordance and understanding would be improved if they were informed of the chemoprophylactic potential of the medication.Adam Low Melanie Love Robert Walt Katherine Kane Bertus Eksteen Jason Goh 2010World Journal of Gastroenterology2010,16,5:2
3Clinical predictors of thiopurine-related adverse events in Crohn's disease显示文摘AIM: To determine the incidence and predictors of thiopurine-related adverse events. METHODS: Subjects with Crohn's disease who were followed in the Alberta Inflammatory Bowel Disease Consortium patient database registry were identified. Retrospective chart review was conducted between August 5th, 2010 and June 1st, 2012. We collected data on: age at diagnosis; sex; disease location and behaviour at time of prescribing thiopurine; perianal fistulising disease at or prior to thiopurine prescription; smoking status at time of thiopurine prescription, use of corticosteroid within 6 mo of diagnosis; dosage, age at onset, and cessation of 5-aminosalicyclic acid(5-ASA); anti-tumour necrosis factor medication exposure and intestinal resection before thiopurine prescription. The primary outcome of interest was the first adverse event that led to discontinuation of the first thiopurine medication used. Logistic regression models were used to associate clinical characteristics with outcomes after adjusting for potential confounders. Risk estimates were presented as odds ratios(OR) with 95% CI. Effect modification by age and sex were explored.RESULTS: Our cohort had a median follow-up duration of 5.8 years [interquartile range(IQR 25th-75th) 2.7-9.1]. Thiopurine therapy was discontinued in 31.3% of patients because of: hypersensitivity reactions(7.1%), acute pancreatitis(6.2%), gastrointestinal intolerance(5.4%), leucopenia(3.7%), hepatotoxicity(3.4%), infection(1.1%) and other reasons(4.3%). A higher incidence of thiopurine withdrawal was observed in patients over the age of 40(39.4%, P = 0.007). A sexby-age interaction(P = 0.04) was observed. Females older than 40 years of age had an increased risk of thiopurine discontinuation due to an adverse event(age above 40 vs age below 40, adjusted OR = 2.8; 95%CI: 1.4-5.6). In contrast, age did not influence thiopurine withdrawal in males(age above 40 vs below 40, adjusted OR = 0.9; 95%CI: 0.4-2.1). Other clinical variables(disease location and phenotype, perianal disease, smoking history, history of intestinal resection and prior 5-ASA or corticosteroid use) were not associated with an increased risk an adverse event leading to therapy cessation. CONCLUSION: Thiopurine withdrawal due to adverse events is commoner in women over the age of 40 at prescription. These findings need to be replicated in other cohorts.Gordon W Moran Marie-France Dubeau Gilaad G Kaplan Hong Yang Bertus Eksteen Subrata Ghosh Remo Panaccione 2015World Journal of Gastroenterology2015,21,25:2
4Morbilliviruses and human disease显示文摘Rima Bertus K Duprex W Paul 2006The Journal of Pathology2006,208,2:1
5显示文摘 2003Current Opinion in Microgbiology2003,6,:1
6Direct pro-arrhythmogenic effects of angiotensin Ⅱ can be suppressed by AT1 receptor blockade in human atrial myocardium显示文摘von Lewinski D Kocksk(a)mper J Rübertus SU 0,,:1
7CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver显示文摘Ye Htun Oo Vanessa Banz Dean Kavanagh Evaggelia Liaskou David R. Withers Elizabeth Humphreys Gary M. Reynolds Laura Lee-Turner Neena Kalia Stefan G. Hubscher Paul Klenerman Bertus Eksteen David H. Adams 2012Journal of Hepatology2012,,5:1
8Extremophiles as a source for novel enzymes显示文摘Bertus van den Burg 2003Current Opinion in Microbiology2003,6,3:1
9License valuation in the aerospace industry:A real options approach显示文摘LUKE MILLER MARK BERTUS 0,,14:1
10Pd,/Ag-catalyzed direct cou- pling of 1 -trimethylsilyl alkynes with vinyl triflates 显示文摘Bertus P Halbes U Pale P 2001European Journal of Organic Chemistry2001,23,:1
11License valuation in the aerospace industry: A real options approach显示文摘Luke Miller Mark Bertus 2005Review of Financial Economics2005,,3:1
12Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells显示文摘Rodrigo Mora J Rodrigo M Makoto I Bertus E 2006SCIENCE2006,314,:1
13Cloning and Secreted Expression of the Extracellular Domain of the Mumps Virus Fusion Protein in Pichia pastoris显示文摘Barry McAleer Bertus Rima 2000Virus Genes2000,,2:1
14Extremophiles as a source for novel enzymes显示文摘 2003Current Opinion in Microbiology2003,6,:1
15A gene from the human Sex-determining region encodes a pretein with homology to a Conserved DNA-binding motif显示文摘Sinclair AH Bertu P Palmer MS 1990Nature1990,346,6281:1
16Noise,equity prices,and hedging A new approach 显示文摘Bertus M 2008International Review of Financial Analysis2008,17,:1
17Direct pro-arrhythmogenic effects of angiotensin Ⅱ can be suppressed by AT1 receptor blockade in human atrial myocardium显示文摘VON LEWINSKI D KOCKSK(A)MPER J R(U)BERTUS S U 2008Eur J Heart Fail2008,10,12:1
18Rational Speculative Bubbles in The Gold Futures Market: An Application of Dynamic Factor Analysis显示文摘Mark Bertus Bryan Stanhouse 2001The Journal of Futures Markets2001,21,1:1
19Extremophiles as a source for novel enzymes显示文摘Bertus van den Burg 2003Current Opinion in Microbiology2003,,3:1
20Extremophiles as a source for novel enzymes显示文摘Bertus van den Burg 2003Current Opinion in Microbiology2003,,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费